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ABSTRACT 
Background: In adults, high blood pressure (BP), adverse serum lipids, and smoking associate 
with cognitive deficits. The effects of these risk factors from childhood on midlife cognitive 
performance are unknown. 
Objectives:  The aim of this study was to investigate the associations between 
childhood/adolescence cardiovascular risk factors and midlife cognitive performance.   
Methods: From 1980, a population-based cohort of 3596 children (baseline age 3-18 years) have 
been followed-up for 31 years in 3-9 year intervals. BP, serum lipids, body mass index and 
smoking were assessed in all follow-ups. Cumulative exposure as the area under the curve for 
each risk factor was determined in childhood (6-12 years), adolescence (12-18 years) and young 
adulthood (18-24 years). In 2011, cognitive testing was performed in 2026 participants aged 34-
49 years.  
Results: High systolic BP, elevated serum total-cholesterol and smoking from childhood were 
independently associated with worse midlife cognitive performance, especially memory and 
learning. The number of early life risk factors, including high levels (extreme 75th percentile for 
cumulative risk exposure between ages 6-24) of systolic BP, total-cholesterol and smoking 
associated inversely with midlife visual and episodic memory and visuospatial associative 
learning (-0.140 standard deviations per risk factor, p<0.0001), and remained significant after 
adjustment for contemporaneous risk factors. Individuals with all risk factors within 
recommended levels between ages 6-24 performed 0.29 standard deviations better (p=0.006) on 
this cognitive domain than those exceeding all risk factor guidelines at least twice. This 
difference corresponds to the effect of six years aging on this cognitive domain. 
Conclusions: Cumulative burden of cardiovascular risk factors from childhood/adolescence 
associate with worse midlife cognitive performance independent of adulthood exposure.  
Key words: cognitive performance, blood pressure, serum cholesterol, body mass index, 
smoking 
Abbreviations 
ApoE = Apolipoprotein E 
AUC = Area under the curve 
BMI = Body mass index 
BP = Blood pressure  
HDL = High density lipoprotein 
LDL = Low density lipoprotein 
PAL = Paired associates learning test 
RTI = Reaction time test 
RVP = Rapid visual information processing test 
SE = Standard error 
SD = Standard deviation 
SWM = Spatial working memory test 
YFS = The Cardiovascular Risk in Young Finns Study 
Condensed Abstract: In adults, high blood pressure (BP), adverse serum lipids, and smoking 
associate with cognitive deficits, but the effects from childhood are unknown.  From 1980, a 
population-based cohort of 3596 children (age 3-18 years) have been regularly followed-up for 
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31 years. BP, serum lipids, body mass index and smoking were assessed in all follow-ups. In 
2011, cognitive testing was performed in 2026 participants aged 34-49 years. High systolic BP, 
elevated serum total-cholesterol and smoking from childhood were independently associated 
with worse midlife cognitive performance, especially memory and learning. Our findings support 
active controlling of cardiovascular risk factors from childhood. 
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Introduction 
Epidemiological evidence indicates that exposure to midlife high blood pressure (BP), 
adverse serum lipids, and smoking associate with cognitive decline later in life (1-4). Studies in 
animal models have also observed associations between these risk factors and cognitive 
performance. Spontaneously hypertensive rats show cognitive decline compared to normotensive 
strains (5). In rodents (6,7), the high-fat diet induced hypercholesterolemia leads to memory 
deficits. In addition, adolescent rats exposed to nicotine show long-lasting cognitive deficits (8). 
Although the mechanisms underlying these associations are largely unclear, experimental studies 
have suggested that cardiovascular risk factors may damage both neuronal and vascular tissues 
of the brain. Studies in rodents have shown that hypertension may alter cerebral vasculature, and 
eventually lead to restrained function of the blood-brain barrier (9). Moreover, experiments on 
rodents have indicated that diet induced hypercholesterolemia may influence the expression of 
genes in the brain relevant for cellular mechanisms for learning, memory and neurodegeneration 
(10). Simultaneously, experiments on rodent and rabbit brains have shown evidence that 
hypercholesterolemia may induce inflammatory changes (6,7,11), and associate with disturbed 
beta-amyloid metabolism (6,7,11). Furthermore, experimental evidence on rodent brain have 
suggested that smoking exposure may induce oxidative stress (12-14) which may trigger cerebral 
inflammatory changes (12), and lead to neuropathological changes related to cognitive decline 
such as accumulation of beta-amyloid peptide and phosphorylation of tau protein (13). 
It is therefore plausible that exposure to cardiovascular risk factors in early life may 
affect later cognitive performance. In support of this hypothesis, a link between cumulative 
burden of young adulthood cardiovascular risk factors and cognitive performance was shown in 
young and middle aged adults in the CARDIA cohort (15). Whether a similar link exists between 
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early life risk exposure and adulthood cognitive function is unknown. We addressed this 
knowledge gap in the Cardiovascular Risk in Young Finns Study (YFS) that has followed a 
population-based sample of individuals from childhood to adulthood. As a part of the 31-year 
follow-up study, cognitive testing was performed using a test battery focusing on several 
cognitive domains that are related to brain structures typically affected in the early stages of 
cognitive decline (16). We hypothesized that a greater burden of cardiovascular risk factors in 
childhood, adolescence and young adulthood, including repeatedly assessed BP, serum lipids, 
and smoking, associate with worse cognitive performance in midlife. 
Methods 
Population 
This study is a part of the national YFS, which is an ongoing longitudinal population-
based study on cardiovascular risk factors from childhood to adulthood. The first cross-sectional 
study including 3596 randomly selected children and adolescents (boys and girls; aged 3, 6, 9, 
12, 15 and 18 years) was performed in 1980. The cohort has been followed-up in regular 
intervals in 1983, 1986, 1989, 2001, 2007, and the latest follow-up study was conducted in 2011. 
Detailed information on the population and protocol is reported elsewhere (17). 
Procedures and measurements 
Outcome measure cognition 
In 2011, a computerized cognitive testing battery (CANTAB®) was used to assess 
cognitive performance in 2026 participants. The YFS test battery included: 1) motor screening 
test used as a training/screening tool to indicate difficulties in test execution, 2) paired 
associates learning test (PAL) measured visual and episodic memory and visuospatial 
associative learning, 3) spatial working memory test (SWM) measured short term and spatial 
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working memory and problem solving, 4) reaction time test (RTI) measured reaction and 
movement speed and attention, and 5) rapid visual information test (RVP) measured visual 
processing, recognition and sustained attention.  
Each test produced several variables. Principal component analysis was conducted to 
identify components accounting for the majority of the variation within the dataset. Principal 
components were created for each test for performance in specific cognitive domains. The motor 
screening test component was excluded from further analyses due to ceiling effect (i.e. all 
participants had the maximum score in this test). Other components were normalized using rank 
order normalization procedure resulting in four variables, each with mean 0 and standard 
deviation (SD) 1. All available data for each cognitive test was used in the analyses, and 
therefore, the number of participants varies between the models (N=177 were excluded due to 
technical reasons in some of the test domains and N=51 refused to participate in all or some of 
the tests). Detailed description and validation of the cognitive data has been reported previously 
(18). 
Exposure variables blood pressure, serum lipids, body mass index and smoking 
Standard methods were used for measuring BP, serum total-cholesterol, high-density 
lipoprotein (HDL) cholesterol, and triglycerides at baseline and all follow-up studies. Low 
density lipoprotein (LDL) cholesterol was calculated according to Friedewald’s (19). Details of 
these methods have been described previously (20). At all study phases, the participants’ weight 
and height were measured and BMI was calculated. To utilize all available repeatedly measured 
exposure data for continuous variables, we estimated subject-specific curves for cardiovascular 
risk factors by mixed model regression splines (21). The area under the curve (AUC) for 
continuous risk variables was evaluated to indicate a long term burden of each measured attribute 
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(22). The AUC variables were defined separately for childhood (6-12 years), adolescence (12-18 
years), young adulthood (18-24 years) and early life (6-24 years). For interpretability, the AUC 
variables were standardized resulting in variables with mean 0 and SD 1. Smoking exposure was 
queried throughout the follow-up time. Smoking status was dichotomized into daily smokers and 
non-smokers, defined as current daily smoking (yes/no) at the baseline or at any of follow-up 
studies when the participants were aged 12-24 years. 
In addition to studying the associations using continuous AUC variables and the 
dichotomized smoking variable, the combined effect of several risk factors from childhood to 
young adulthood on midlife cognitive performance was analysed. For that purpose, a 3-level 
variable indicating the number of cardiovascular risk factors during early life (6-24 years) was 
created (1=no risk factors, 2=one risk factor, 3=two or three risk factors) including the variables 
that showed significant association with cognitive performance in the multivariate analyses (i.e. 
systolic blood pressure, serum total-cholesterol and smoking). To define risk factors using the 
continuous AUC variables, the distributions of BP and serum total-cholesterol were 
dichotomized into high (≥75th percentile) and low (<75th percentile) risk factor levels (sensitivity 
analyses were additionally performed by using cut-points of 70th, 80th and 85th percentiles). Such 
dichotomized variables and the binary smoking variable were summed to create the variable 
indicating the number of risk factors (range 0-3) during early life. The age and sex specific mean 
values of systolic blood pressure, total- and LDL-cholesterol corresponding to the highest 75th 
percentile of the AUC variables between ages 6-24 years are presented in Online Table 1. A 
similar variable indicating the number of midlife risk factors at the time of cognitive testing was 
constructed. Current midlife daily smoking was queried at the time of cognitive testing and 
categorized as non-smokers vs. daily smokers. 
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In addition to the arbitrarily selected risk factor cut-points, we examined whether the 
effect of early life risk exposure is attributable to levels of risk factors repeatedly exceeding the 
recommended guidelines. The age and sex specific cut-points were considered for variables 
showing significant effect for cognitive performance in the multivariate analyses i.e. systolic BP 
(23), LDL-cholesterol (24), and smoking (25). The exact cut-points for these risk factors are 
presented in Online Table 2. The participants were classified into: 1) no risk factor levels 
exceeding guidelines or levels exceeding at most once per risk factor, 2) risk factor levels 
exceeding guidelines on one risk factor at least twice, 3) risk factor levels exceeding guidelines 
at least twice on two risk factors, 4) risk factor levels exceeding guidelines at least twice on all 
risk factors. 
Covariates  
The following primary covariates were used in the analyses: age, sex, baseline household 
income, antihypertensive and dyslipidemia medication, diagnoses of cardiovascular diseases and 
type 1 and 2 diabetes mellitus. Altogether 1,901 individuals with cognitive test data had 
complete data on exposure variables and primary covariates.  Age was defined in full years at the 
end of the year 2011. Baseline household income, use of antihypertensive (N=192) or 
dyslipidemia (N=72) medication and type 1 diabetes diagnoses (N=12) were queried. 
Participants were classified as having type 2 diabetes based on self-reported and register 
confirmed diagnosis, self-reported glucose lowering medication or abnormal plasma glucose or 
haemoglobin A1c values (N=75). Diagnoses of cardiovascular diseases (N=13) were adjudicated 
from the national hospital discharge register. Additionally, data on following covariates were 
available for restricted numbers of participants, and were therefore used in additional analyses: 
childhood academic performance (N=1684), adulthood education (N=1894), apolipoprotein E 
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(apoE) genotype (N=1803), and adulthood physical activity (N=1884). Childhood academic 
performance expressed as grade point average (i.e. mean of grades in all individual school 
subjects at baseline or either of the two subsequent follow-ups for those participants who were 
not of school age at baseline) was queried and used as a proxy for childhood cognitive ability. 
Adulthood education was assessed with questionnaires at the follow-up studies in 2001, 2007 
and 2011. The maximum years of education was determined as a continuous variable from self-
reported data concerning total years of education. ApoE genotypes were analysed with standard 
methods and the individuals were divided into apoEε4 carriers (≥one ε4 allele) and non-carriers 
(no ε4 alleles). Physical activity was queried and the level of physical activity was calculated as 
the mean of the adulthood (ages 24-49 years) physical activity indexes (range 5-15). Detailed 
description of the covariates is presented in the Online Appendix. 
Statistical analyses 
Student’s t-test was applied for continuous variables and χ2-test for categorical variables. 
Linear regression analyses were conducted to examine the associations between 
childhood/adolescence/young adulthood cardiovascular risk factors and midlife cognitive 
performance. First, age and sex adjusted regression analyses were conducted separately for 
cumulative burden of each cardiovascular risk factor in childhood, adolescence and young 
adulthood using each cognitive domain as outcome. After that, family income, antihypertension 
and dyslipidemia medication and diagnoses of cardiovascular diseases and diabetes mellitus 
were entered as covariates in these analyses. 
Second, further analyses were conducted for visual and episodic memory and visuospatial 
associative learning (PAL-test) which was the cognitive domain showing most consistent results 
in the analyses separately for each early life cardiovascular risk factors. These analyses were 
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conducted first unadjusted, and then entering age and sex as covariates. After that, all early life 
cardiovascular risk factors were entered in the same age and sex adjusted model. Then, the 
analyses were additionally adjusted for family income, antihypertension and dyslipidemia 
medication and diagnoses of cardiovascular diseases and diabetes mellitus. Due to high 
intercorrelation (r=0.94) between total- and LDL-cholesterol, these variables showed essentially 
similar relations with the cognitive domains, and were not considered simultaneously in the 
multivariable models. Finally, all analyses were further adjusted for childhood academic 
performance, adulthood education, apoEε4 and adulthood physical activity. Additionally, we 
tested the possible effect modification caused by sex or age on the associations between 
cardiovascular risk factors and performance on those cognitive domains that showed significant 
results in the multivariate models. The possible effect modification was analysed by adding 
interaction terms in the fully adjusted multivariate models. No significant interactions were 
found (data not shown). All statistical analyses were performed using SAS 9.4 and p<0.05 as the 
level of significance. Detailed description of all statistical methods is presented in the Online 
Appendix. 
Results  
Characteristics of the population 
The characteristics of the study population and numbers of participants in each separate 
cognitive test are shown in Online Table 3. The representativeness of the study population 
participating in the cognitive testing was examined by comparing the baseline differences 
between participants and non-participants (Online Table 4). Participants were more often women 
and older than non-participants. In addition, they originated from families with higher income 
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and had better childhood academic performance. No differences were observed in the exposure 
variables. 
Cardiovascular risk factors in childhood, adolescence and young adulthood 
Associations between childhood (6-12 years), adolescence (12-18 years) and young 
adulthood (18-24 years) cardiovascular risk factors and midlife cognitive performance are shown 
in Online Table 5. The consistent finding was that elevated systolic BP and adverse lipids (high 
total- or LDL-cholesterol) in childhood, adolescence and young adulthood, as well as cigarette 
smoking in adolescence and young adulthood, associated systematically with lower midlife 
visual and episodic memory and visuospatial associative learning (PAL-test) (detailed results in 
the Online Table 5). In general, the effect estimates of cardiovascular risk factors for the PAL-
test were similar across all exposure age categories. Additionally, we found some links of serum 
total-cholesterol, triglycerides, smoking and BMI to the test measuring sustained attention and 
visual processing (RVP-test).  However, only the results for the PAL-test remained consistently 
unchanged after further adjustments for family income, antihypertension and dyslipidemia 
medication and diagnoses of cardiovascular diseases and diabetes mellitus. Therefore, detailed 
results are presented to examine the independent effects of early life cumulative burden of 
systolic BP, serum total-cholesterol, BMI and smoking on PAL-test performance: First, we 
calculated the mean values of the midlife PAL-test performance and each cardiovascular risk 
factor in childhood (age 6-9 years), adolescence (age 12-15 years) and early adulthood (age 18-
24 years) within the quartiles of the early life AUC variables for the same risk factors (Table 1). 
We also calculated the difference in cognitive age across the quartiles in the PAL-test 
performance based on our previous study that showed a -0.05 SD decline per year in the YFS 
population.18 For example, the table shows a 0.42 SD difference between the extreme systolic 
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blood pressure quartiles. This corresponds to 8.4 years difference in cognitive age. Similarly, we 
see a 0.33 SD difference between the extreme serum total-cholesterol quartiles (6.6 years) and a 
0.17 SD difference between smokers and non-smokers (3.4 years). 
Second, analyses were conducted to examine the independent effects of early life 
(between ages 6-24 years) cumulative burden of systolic BP, serum total-cholesterol, BMI and 
smoking on midlife visual and episodic memory and visuospatial learning (PAL-test) (Table 2). 
In the unadjusted bivariate analyses (Table 2, row A), early life exposure to elevated systolic 
blood pressure, serum total-cholesterol and smoking were inversely related with the PAL-test 
performance. These associations were attenuated but remained significant when the effects of 
age and sex were taken into account (Table 2, row B), when mutually adjusted for in a 
multivariate model (Table 2, row C) and when additionally adjusted for family income, 
antihypertension and dyslipidemia medications and diagnoses of cardiovascular disease and 
diabetes mellitus (Table 2, row D). This indicates that all three risk factors were independently 
associated with the PAL-test performance and that none of the other covariates had significant 
confounding effects. 
Further multivariate analyses were conducted including childhood academic 
performance, adulthood education, apoEε4 genotype, and adulthood physical activity level as 
covariates in the model. In this sample, the results for BP and serum total-cholesterol remained 
essentially similar for visual and episodic memory and visuospatial associative learning (PAL-
test, N=1450, systolic BP: β=-0.065, SE=0.031, p=0.034; serum total-cholesterol: β=-0.076, 
SE=0.028, p=0.006), but the additional adjustments diluted the effects of smoking for visual and 
episodic memory and visuospatial associative learning (PAL-test, N=1450, smoking: β=-0.032, 
SE=0.060, p=0.60) and for recognition, visual processing and sustained attention (RVP-test, 
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N=1545, smoking: β=-0.033, SE=0.057, p=0.568). The covariate that was mainly responsible for 
the dilution of the effect of smoking was childhood academic performance, which was directly 
and highly significantly (p-value always <0.008) associated with all midlife cognitive domains. 
Multiple cardiovascular risk factors 
Because early life cardiovascular risk factors associated systematically with visual and 
episodic memory and visuospatial associative learning (PAL-test), the effects on that cognitive 
domain were investigated in relation to 1) the number of early and midlife cardiovascular risk 
factors, and 2) the number of early life risk factors exceeding the recommended guidelines. 
Number of early and midlife cardiovascular risk factors 
Persons with none or one risk factor (defined as continuous AUC values exceeding the 
75th percentile and frequent smoking) during their early life (age 6-24 years) performed better in 
the PAL-test than participants with 2-3 early life cardiovascular risk factors. After adjusting for 
age, sex, family income, antihypertension and dyslipidemia medications and diagnoses of 
cardiovascular diseases and diabetes mellitus, the association between the number of early life 
cardiovascular risk factors and midlife cognitive performance was highly significant (N=1733; 
β=-0.135, SE=0.034, p<0.0001). Similar but weaker association between the number of risk 
factors and PAL-test was found for current midlife cardiovascular risk factors (N=1781; β=-
0.078, SE=0.034, p=0.022).  
To examine whether the effect of early life risk factors on PAL-test were independent of 
the effect of contemporaneous risk factors, we stratified the cohort into groups according to the 
number of early and midlife risk factors (Figure 1). When simultaneously entered in a 
multivariable model, the effect of early life risk factors remained significant (N=1733; β=-0.119, 
SE=0.036, p=0.001), but the effect of the midlife risk factors was diluted (β=-0.045, SE=0.037, 
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p=0.220). The ‘independent’ effect of early risk exposure is illustrated in Figure 1. For example, 
individuals who have been exposed to several risk factors in early life have consistently of about 
0.25 SD’s lower memory and learning compared to the population mean regardless of the 
number of contemporary risk factors (red dots in Figure 1). This corresponds about 5 years in 
cognitive aging in our population. These results remained essentially similar after further 
adjustments with childhood academic performance, adulthood education, apoEε4 genotype, and 
physical activity level (N=1450; early life risk factors: β=-0.116, SE=0.040, p=0.004; midlife 
risk factors: β=0.004, SE=0.040, p=0.916). 
In addition to the 75th percentile cut-point used in the main analyses, we performed 
sensitivity analyses for the association between the number of risk factors and cognitive 
performance using cut-points of 70th, 80th, and 85th percentiles for determining the risk factor 
levels. The associations between the number of early and midlife cardiovascular risk factors and 
midlife cognitive performance remained virtually unchanged regardless the cut-point used 
(Online Table 6). Thus, by using several risk factor percentile cut-points, the number of early-life 
risk factors remained robustly associated with mid-life memory and learning. And when the 
models were simultaneously controlled for the mid-life risk factors, the effect of early life risk 
factors remained significant, but the effects of the midlife risk factors were always diluted. 
Furthermore, all models gave identical results if high total-cholesterol was replaced with high 
LDL-cholesterol in the risk scores. 
Number of early life risk factors exceeding the recommended guidelines 
In addition to the risk factor levels based on percentile cut-points, we examined whether 
the effect of early life risk exposure is attributable to levels of risk factors repeatedly exceeding 
the recommended guidelines for pediatric atherosclerosis prevention using cut-points shown in 
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Online Table 2. The analyses considering risk factors exceeding recommended guidelines 
indicated that the persons with early life risk factors within the recommended guidelines had 
0.29 SD better visual and episodic memory and visuospatial associative learning (PAL-test) than 
those exceeding the guidelines at least twice on all risk factors (model adjusted for age, sex, 
family income, antihypertension and dyslipidemia medications and diagnoses of cardiovascular 
diseases and diabetes mellitus: N=1568; β=-0.088, SE=0.032, p=0.007) (Figure 2). This effect 
remained identical after further adjustments with childhood academic performance, adulthood 
education, apoEε4 genotype, and physical activity level (N=1341; β=-0.077, SE=0.035, 
p=0.029). 
Discussion 
We found that increasing cumulative burden of systolic BP, serum total- and LDL-
cholesterol and smoking in childhood/adolescence associated with worse visual and episodic 
memory and visuospatial associative learning at midlife (PAL-test). Importantly, the associations 
were independent of midlife exposures to the same risk factors. These findings suggest that the 
associations between early life cardiovascular risk factors and midlife cognitive performance do 
not only reflect tracking of risk factor levels from childhood to adulthood, but that the risk 
factors potentially start to exert their influence on cognitive performance already in childhood. 
Previous studies have observed inverse associations between adulthood systolic BP, 
serum cholesterol, BMI and smoking and midlife cognitive performance (15) or risk of late-life 
cognitive deficits (1-4). To the best of our knowledge, this is the first study examining the 
cumulative burden of cardiovascular risk factors from childhood in relation to cognitive 
performance in midlife. Of the risk factors examined, we were able to demonstrate the 
independent effects of early life systolic BP, serum total- and LDL-cholesterol, and smoking. 
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Participants with these early life risk factors, factored as continuous or binary variables, defined 
either by using several arbitrary cut-points or by using current guidelines for atherosclerosis 
prevention, had worse midlife cognitive performance than those with low risk factor levels. 
Although the observational nature of our study precludes making clinical recommendations, it 
provides evidence on cognitive benefits gained by maintenance of cardiovascular risk factors at 
low levels already from early life. If this hypothesis is correct, adopting active monitoring and 
treatment strategies against cardiovascular risk factors from childhood would be needed to turn 
the focus of cognitive deficits prevention from secondary and tertiary prevention to primordial 
prevention. With the future YFS follow-up data on cognitive performance, we will be able to 
estimate using observational data whether changes in risk factor levels from childhood to 
adulthood associate with the deterioration of cognitive function between mid- to old adulthood. 
The four cognitive domains were selected as outcomes in order to obtain a 
comprehensive outlook to cognitive performance. Based on previous experimental studies in 
animals, we especially expected to see links between cardiovascular risk factors and tests 
indicating memory and learning. Indeed, we found that the effects of early life risk exposure was 
strongly and robustly associated with the visual and episodic memory and visuospatial 
associative learning (PAL-test). Similarly, the CARDIA study found strong associations between 
serum total-cholesterol, blood pressure and verbal memory (15). Additionally, we found weak 
links of smoking and BMI to the test measuring sustained attention and visual processing (RVP-
test) that were of borderline significant or not did survive adjustments. The CARDIA study used 
Stroop test that resembled the RVP-test used in our study, and found some associations with 
systolic blood pressure (15). We did not find associations between risk exposures and working 
memory (SWM-test) or reaction time (RTI-test). Effects on the reaction time were not expected 
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based on previous animal data. Additionally, the lack of effects of risk factor exposure on 
working memory in midlife is perhaps also not surprising because difficulties in encoding and 
recall might become visible prior to difficulties in other type of memory functions (e.g. working 
memory, recognition) (26). Thus, our results are consistent with studies in animal models that 
have observed associations between cardiovascular risk factors and memory and learning. 
The neural networks related to the PAL-test localize mainly to medial temporal lobes, 
specifically to hippocampus and parahippocampal gyrus (16).  These anatomical structures are 
responsible for learning and memory (27). Imaging studies have reported that exposure to 
cardiovascular risk factors is associated with increased amount of cerebral white matter 
alterations and structural brain changes in the elderly (28-31) and augment the effect of age on 
volume loss in hippocampus, entorhinal cortex and medial temporal lobes in healthy adults (32). 
These findings may offer insights into the associations between early cardiovascular risk factors 
and medial temporal lobe related brain functions. Furthermore, in elderly patients with mild 
cognitive impairment, deficits in the PAL-test have been linked to preclinical Alzheimer’s 
disease pathology (33-36). 
The main neuropathological mechanisms underlying associations between cardiovascular 
risk factors and old-age cognitive deficits are suggested to be subclinical ischemia causing 
cerebrovascular damage (27,37), structural brain changes and atrophy (28-31). Additionally, risk 
factors may influence cerebral β-amyloid protein metabolism (38,39). In young populations, 
however, the mechanisms remain unknown. Cardiovascular risk factors cause systemic 
atherosclerosis, loss of distensibility in the vasculature, vessel fibrosis, plasma protein leakage, 
and accumulation of lipid-containing macrophages in the vessels (40-42). In the brain, these 
changes may lead to cerebral hypoperfusion and local inflammation which disrupt the vulnerable 
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surrounding neuronal milieu (37). Additionally, by inducing cerebral hypoperfusion 
atherosclerotic changes may initiate and/or accelerate neurodegenerative changes (e.g. β-amyloid 
deposition and clearance, synaptic and neuronal dysfunction/loss) that ultimately lead to 
alterations in cognitive performance (38,39). 
We found that the participants with several early life cardiovascular risk factors, 
including elevated BP, high LDL-cholesterol and smoking, exceeding the recommended 
guidelines had ~0.3 SD’s lower performance in the PAL-test than those participants whose risk 
factors remained always within the guidelines. When using arbitrary cut-points for BP and total-
cholesterol (exceeding 75th percentiles), we similarly found that individuals who had been 
exposed to all three risk factors in early life had ~0.4 SD’s lower performance in the PAL-test 
than individuals without any early life risk factor exposures. In the YFS population, we see a 
linear decline in the PAL-test performance that equals to 0.05 SD’s per year between ages 34 and 
49 (18). Therefore, the present study suggests that the effect of early life risk factor clustering on 
the PAL-test performance corresponds to 6-8 year difference in cognitive age. Furthermore, we 
found that the cumulative effect of the early life risk exposure on the PAL-test performance was 
stronger and independent of the effect of current midlife risk exposure. This observation 
emphasizes the role of early life risk exposure on later cognitive performance, and may be in line 
with the existence of differential sensitive periods and age windows of vulnerability to 
environmental factors and conditions during brain maturation (43). 
Limitations of this study include that cognitive performance was measured once. 
Currently, this prevents us from studying the role of early life cardiovascular risk factors on 
changes in midlife cognitive performance. Furthermore, we were unable to examine the role of 
glucose levels as an early life risk factor because we did not have data to construct a cumulative 
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exposure variable similarly to systolic blood pressure and serum total-cholesterol. However, the 
CARDIA study found no association between young adulthood/midlife cumulative blood 
glucose burden and midlife cognitive performance among normoglycemic population (15). 
Another limitation is the possibility of residual confounding due to unmeasured factors, which is 
always possible in observational studies like the YFS. Our results remained unchanged after 
controlling the analyses for a wide array of possible confounding factors including the adulthood 
levels of cardiovascular risk factors. It remains possible, however, that some unmeasured factors 
contribute to the association between cardiovascular risk factors and cognitive performance. 
Furthermore, computerized cognitive tests are not routinely used in clinical settings to diagnose 
cognitive performance. In this study, the test battery was not used for clinical decision making, 
but as a tool to evaluate cognitive performance among healthy young and middle aged adults on 
a population level. Previous studies have shown that these tests are useful in capturing variation 
in cognitive performance in healthy populations (44-46). Therefore, the tests used in the YFS 
may be considered adequate in discriminating the cognitive variation among the participants. 
Another potential limitation is a possible selection in the follow-up study - the participants were 
more often women and older than non-participants, and they originated from families with higher 
income and had better childhood academic performance. However, no differences were observed 
in the levels of early life exposure variables. Furthermore, we conducted several statistical tests 
in our study, which may increase the probability of false positive findings. However, as the main 
analyses were based on a priori hypotheses, we did not apply multiple testing correction. 
Moreover, with respect to the establishment of causality, observational studies are prone to bias 
caused by reverse causation. Nevertheless, the use of existing population cohorts from childhood 
to adulthood is the only realistic approach to test the hypothesis that early life risk exposure is 
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causally linked with adult cognitive performance, as it is not possible to perform life-long 
randomized control trials to test causal relations between childhood risk factors and adult 
outcomes. The most important competing explanation for these associations is that cognitive 
function in early life might determine (or might associate with other factors determining) the 
emergence of vascular risk factors. If that hypotheses was true, midlife cognitive performance 
would simply be a marker of tracked early life cognitive function. We were able to test this 
hypotheses in a restricted number of the YFS participants by using available data on academic 
performance as a proxy for their childhood cognitive performance. Academic performance was 
defined as grade point average, which indicates the mean of all school grades during one school 
year. As an overall measure of academic performance it may be considered as an indicator of the 
participants’ cognitive ability at baseline. Indeed, when introduced as a covariate, the effect of 
smoking was diluted. This suggests that the association between early life smoking and midlife 
cognitive performance might be confounded by baseline cognitive performance. However, the 
effects of other risk factors as well as the effect of the early life risk factor clustering remained 
essentially similar after taking account the childhood academic performance. Nevertheless, as the 
possibility of residual confounding remains, the results in YFS should be replicated in other 
longitudinal cohorts with follow-up from childhood to adulthood. 
Conclusions 
In summary, these data indicate that the cumulative burden of BP, serum total- and LDL-
cholesterol, and smoking from childhood and adolescence associate independently and combined 
with midlife cognitive performance. The findings give support to active monitoring/treatment 
strategies against cardiovascular risk factors from childhood in order to turn the focus of 
cognitive deficits prevention to primary prevention. 
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Perspectives 
Competency in medical knowledge 
Cumulative burden of systolic BP, serum total- and LDL-cholesterol and smoking in 
childhood/adolescence associate with worse cognitive performance, especially memory and 
learning, at midlife. Importantly, the associations were independent of midlife exposures to the 
same risk factors. These results give support to active monitoring and treatment strategies against 
cardiovascular risk factors already earlier during the lifespan in order to promote adulthood 
cognitive health. The findings from the current study elucidate the possibilities to move the focus 
of cognitive decline prevention from secondary and tertiary prevention to primordial prevention 
through affecting cardiovascular risk factors already from childhood and adolescence. 
 
Translational outlook 
The molecular mechanisms of childhood/adolescence cardiovascular risk factors on cognitive 
decline from young adulthood to middle and old age require further investigation.  
 
  
23 
References 
1.  Knopman D, Boland LL, Mosley T, et al. Cardiovascular risk factors and cognitive 
decline in middle-aged adults. Neurology. 2001;56:42-48. 
2.  Tolppanen A-M, Solomon A, Soininen H, Kivipelto M. Midlife vascular risk factors and 
Alzheimer’s disease: evidence from epidemiological studies. J Alzheimers Dis. 2012;32:531-
540.  
3.  Rusanen M, Rovio S, Ngandu T, et al. Midlife smoking, apolipoprotein E and risk of 
dementia and Alzheimer’s disease: a population-based cardiovascular risk factors, aging and 
dementia study. Dement Geriatr Cogn Disord. 2010;30:277-284.  
4.  Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment 
and dementia: a statement for healthcare professionals from the american heart 
association/american stroke association. Stroke. 2011;42:2672-2713.  
5.  Grünblatt E, Bartl J, Iuhos D-I, et al. Characterization of cognitive deficits in 
spontaneously hypertensive rats, accompanied by brain insulin receptor dysfunction. J Mol 
psychiatry. 2015;3:6.  
6.  Ullrich C, Pirchl M, Humpel C. Hypercholesterolemia in rats impairs the cholinergic 
system and leads to memory deficits. Mol Cell Neurosci. 2010;45:408-417.  
7.  Thirumangalakudi L, Prakasam A, Zhang R, et al. High cholesterol-induced 
neuroinflammation and amyloid precursor protein processing correlate with loss of working 
memory in mice. J Neurochem. 2008;106:475-485.  
8.  Counotte DS, Spijker S, Van de Burgwal LH, et al. Long-lasting cognitive deficits 
resulting from adolescent nicotine exposure in rats. Neuropsychopharmacology. 2009;34:299-
306.  
24 
9. Ueno M, Sakamoto H, Tomimoto H, et al. Blood-brain barrier is impaired in the
hippocampus of young adult spontaneously hypertensive rats. Acta Neuropathol. 2004;107:532-
538. 
10. Mateos L, Akterin S, Gil-Bea F-J, et al. Activity-regulated cytoskeleton-associated
protein in rodent brain is down-regulated by high fat diet in vivo and by 27-hydroxycholesterol 
in vitro. Brain Pathol. 2009;19:69-80.  
11. Sparks DL, Kuo YM, Roher A, Martin T, Lukas RJ. Alterations of Alzheimer’s disease
in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations. Ann N 
Y Acad Sci. 2000;903:335-344.  
12. Khanna A, Guo M, Mehra M, Royal W. Inflammation and oxidative stress induced by
cigarette smoke in Lewis rat brains. J Neuroimmunol. 2013;254:69-75. 
13. Ho Y-S, Yang X, Yeung S-C, et al. Cigarette smoking accelerated brain aging and
induced pre-Alzheimer-like neuropathology in rats. PLoS One. 2012;7:e36752. 
14. Rueff-Barroso CR, Trajano ETL, Alves JN, et al. Organ-related cigarette smoke-induced
oxidative stress is strain-dependent. Med Sci Monit. 2010;16:BR218-26. 
15. Yaffe K, Vittinghoff E, Pletcher MJ, et al. Early adult to midlife cardiovascular risk
factors and cognitive function. Circulation. 2014;129:1560-1567. 
16. de Rover M, Pironti VA, McCabe JA, et al. Hippocampal dysfunction in patients with
mild cognitive impairment: a functional neuroimaging study of a visuospatial paired associates 
learning task. Neuropsychologia. 2011;49:2060-2070.  
17. Raitakari OT, Juonala M, Rönnemaa T, et al. Cohort profile: the cardiovascular risk in
Young Finns Study. Int J Epidemiol. 2008;37:1220-1226. 
25 
18. Rovio SP, Pahkala K, Nevalainen J, et al. Cognitive Performance in Young Adulthood
and Midlife: Relations With Age, Sex, and Education-The Cardiovascular Risk in Young Finns 
Study. Neuropsychology. 2016:30;532-42.  
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-
density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin 
Chem. 1972;18:499-502.  
20. Porkka K V, Raitakari OT, Leino A, et al. Trends in serum lipid levels during 1980-1992
in children and young adults. The Cardiovascular Risk in Young Finns Study. Am J Epidemiol. 
1997;146:64-77.  
21. Welham S. Longitudinal Data Analysis. In: Fitzmaurice G, Davidian M, Verbeke G,
Molenberghs G, eds. Longitudinal Data Analysis. Chapman & Hall /CRC; 2009:253-289. 
22. Lai C-C, Sun D, Cen R, et al. Impact of long-term burden of excessive adiposity and
elevated blood pressure from childhood on adulthood left ventricular remodeling patterns: the 
Bogalusa Heart Study. J Am Coll Cardiol. 2014;64:1580-1587.  
23. Kaelber DC, Pickett F. Simple table to identify children and adolescents needing further
evaluation of blood pressure. Pediatrics. 2009;123:e972-4. 
24. Jolliffe CJ, Janssen I. Distribution of lipoproteins by age and gender in adolescents.
Circulation. 2006;114:1056-1062. 
25. Kavey R-EW, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K. American
Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease 
beginning in childhood. Circulation. 2003;107:1562-1566.  
26. Drag LL Bieliauskas LA. Contemporary Review 2009: Cognitive Aging. J Geriatr
Psychiatry Neurol. 2010;23:75-93. 
26 
27. Blennow K, de Leon MJ, Zetterberg H. Alzheimer’s disease. Lancet. 2006;368:387-403.
28. Vuorinen M, Solomon A, Rovio S, et al. Changes in vascular risk factors from midlife to
late life and white matter lesions: a 20-year follow-up study. Dement Geriatr Cogn Disord. 
2011;31:119-125.  
29. Knopman DS, Penman AD, Catellier DJ, et al. Vascular risk factors and longitudinal
changes on brain MRI: the ARIC study. Neurology. 2011;76:1879-1885. 
30. Debette S, Seshadri S, Beiser A, et al. Midlife vascular risk factor exposure accelerates
structural brain aging and cognitive decline. Neurology. 2011;77:461-468. 
31. Launer LJ, Lewis CE, Schreiner PJ, et al. Vascular factors and multiple measures of early
brain health: CARDIA brain MRI study. PLoS One. 2015;10:e0122138. 
32. Raz N, Lindenberger U, Rodrigue KM, et al. Regional brain changes in aging healthy
adults: general trends, individual differences and modifiers. Cereb Cortex. 2005;15:1676-1689. 
33. Blackwell AD, Sahakian BJ, Vesey R, Semple JM, Robbins TW, Hodges JR. Detecting
dementia: novel neuropsychological markers of preclinical Alzheimer’s disease. Dement Geriatr 
Cogn Disord. 2004;17:42-48.  
34. Swainson R, Hodges JR, Galton CJ, et al. Early detection and differential diagnosis of
Alzheimer’s disease and depression with neuropsychological tasks. Dement Geriatr Cogn 
Disord. 12:265-280.  
35. Fowler KS, Saling MM, Conway EL, Semple JM, Louis WJ. Computerized
neuropsychological tests in the early detection of dementia: prospective findings. J Int 
Neuropsychol Soc. 1997;3:139-146.  
36. Fowler KS, Saling MM, Conway EL, Semple JM, Louis WJ. Paired associate
performance in the early detection of DAT. J Int Neuropsychol Soc. 2002;8:58-71. 
27 
37. Kalaria RN. Vascular basis for brain degeneration: faltering controls and risk factors for
dementia. Nutr Rev. 2010;68 Suppl 2:S74-87. 
38. Reed BR, Marchant NL, Jagust WJ, DeCarli CC, Mack W, Chui HC. Coronary risk
correlates with cerebral amyloid deposition. Neurobiol Aging. 2012;33:1979-1987. 
39. Rodrigue KM, Rieck JR, Kennedy KM, Devous MD, Diaz-Arrastia R, Park DC. Risk
factors for β-amyloid deposition in healthy aging: vascular and genetic effects. JAMA Neurol. 
2013;70:600-606.  
40. Altman R, Rutledge JC. The vascular contribution to Alzheimer’s disease. Clin Sci
(Lond). 2010;119:407-421. 
41. Grinberg LT, Thal DR. Vascular pathology in the aged human brain. Acta Neuropathol.
2010;119:277-290. 
42. Vasilevko V, Passos GF, Quiring D, et al. Aging and cerebrovascular dysfunction:
contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy. Ann N Y Acad 
Sci. 2010;1207:58-70.  
43. Marco EM, Macrì S, Laviola G. Critical age windows for neurodevelopmental
psychiatric disorders: evidence from animal models. Neurotox Res. 2011;19:286-307. 
44. Koepsell TD, Kurland BF, Harel O, Johnson EA, Zhou X-H, Kukull WA. Education,
cognitive function, and severity of neuropathology in Alzheimer disease. Neurology. 
2008;70:1732-1739.  
45. Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbitt P. Cambridge
Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large 
sample of normal elderly volunteers. Dementia. 5:266-281.  
28 
46. De Luca CR, Wood SJ, Anderson V, et al. Normative data from the CANTAB. I:
development of executive function over the lifespan. J Clin Exp Neuropsychol. 2003;25:242-
254. 
29 
Figure Legends  
Central Illustration: Previous studies have shown that childhood cardiovascular risk 
factors, including high blood pressure, altered serum lipids, high body mass index and 
smoking associate with adulthood levels of these risk factors and also with adulthood 
cardiovascular health. Additionally, previous evidence suggests a link between adulthood 
levels of cardiovascular risk factors and middle/old age cognitive performance. (Previous 
evidence shown with grey arrows in the illustration.) Our present study elucidates the 
associations between cardiovascular risk factors from childhood to early adulthood and midlife 
cognitive performance in the unique population of the Cardiovascular Risk in Young Finns 
Study with 31 years follow-up time (Novel evidence shown with red arrow in the illustration). 
Our results showed that high systolic BP, elevated serum total-cholesterol and smoking from 
childhood were independently associated with worse midlife cognitive performance, especially 
memory and learning. These findings give support to active monitoring/treatment strategies 
against cardiovascular risk factors from childhood in order to turn the focus of cognitive deficits 
prevention to primary prevention by maintenance of cardiovascular risk factors. 
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Figure 1. Midlife performance on episodic memory and visual associative learning 
according to the number of early life and midlife cardiovascular risk factors (N=1733). The 
values represent means and 95% confidence intervals indicating cognitive performance on visual 
and episodic memory and visuospatial associative learning in subgroups classified according to 
the number of risk factors in early- and midlife. The variables showing significant association for 
cognitive performance in the multivariate analyses (i.e. systolic blood pressure, serum total-
cholesterol and smoking) were included in the variable for the cardiovascular risk factor 
clustering. In a multivariable model, the association between the number of early life 
cardiovascular risk factors and midlife cognitive performance was significant (p=0.004) after 
adjustments for age, sex, family income and the number of midlife cardiovascular risk factors. 
The reference line is set on the population mean. A 3-level variable indicating the number of risk 
31 
factors during early life was created from the area under the curve (AUC) variables for each 
cardiovascular risk factor (1=no risk factors, 2=one risk factor, 3=two or three risk factors) and 
the categories were indicated with colors in the figure. The AUC variables for BP and serum 
total-cholesterol were dichotomized into high risk factor level (≥ 75th percentile) and low risk 
factor level (<75th percentile). Smoking status was dichotomized into smokers and non-smokers. 
The dichotomical variables were summed to create the variable indicating the number of risk 
factors (range 0-3) during early life (6-24 years). A similar variable indicating the number of 
cardiovascular risk factors at the time of cognitive testing was formed and placed in the x-axis in 
the figure. 
Figure 2. Midlife performance on episodic memory and visual associative learning 
according to the number of risk factors (high LDL-cholesterol, elevated systolic BP, and 
cigarette smoking) with levels exceeding the recommended guidelines (16-18). The variables 
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showing significant association for cognitive performance and with guideline recommendations 
for children/adolescence (i.e. LDL-cholesterol, systolic blood pressure and smoking) were 
included in the variable for the cardiovascular risk factor clustering. The bars indicate the mean 
values of the principal component for visual and episodic memory and visuospatial associative 
learning and the whiskers are standard errors. The individuals were classified into: 0) no risk 
factor levels exceeding guidelines or levels exceeding at most once per risk factor, 1) risk factor 
levels exceeding guidelines twice or more on one risk factor, 2) risk factor levels exceeding 
guidelines twice or more on two risk factors, 3) risk factor levels exceeding guidelines twice or 
more on all risk factors. The inverse dose-response relation with cognitive performance was 
significant (β=-0.088, p=0.007), adjusted for age, sex, family income, antihypertension and 
dyslipidemia medications and diagnoses of cardiovascular diseases and diabetes mellitus. The 
reference line is set on the population mean.
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Table 1. Performance in the Paired Associates Learning-test, estimated difference in cognitive age and mean values of risk factor 
variables across the early life cumulative cardiovascular risk factor burden. 
Early life risk factor burden (between 
ages 6 and 24 years). 
PAL-test Difference in 
cognitive age* 
Mean (SD) systolic 
blood pressure at 
age  6-9 years 
Mean (SD) systolic 
blood pressure at 
age 12-15 years 
Mean (SD) systolic 
blood pressure at 
age 18-24 years 
The area under the curve variable for 
systolic blood pressure 
1st quartile (n=462) 
2nd quartile (n=461) 
3rd quartile (n=462) 
4th quartile (n=463) 
0.21 (1.00) 
0.09 (0.99) 
-0.09 (0.98) 
-0.21 (0.98) 
ref. 
+2.4 years 
+6.0 years 
+8.4 years 
101.8 (6.1) 
108.3 (6.0) 
111.1 (6.3) 
117.5 (6.8) 
102.9 (6.3) 
110.0 (5.4) 
115.3 (5.5) 
124.3 (8.1) 
107.1 (7.4) 
114.9 (6.1) 
122.6 (5.9) 
132.6 (8.4) 
Mean (SD) serum 
total-cholesterol at 
age 6-9 years 
Mean (SD) serum 
total-cholesterol at 
age 12-15 years 
Mean (SD) serum 
total-cholesterol at 
age 18-24 years 
The area under the curve variable for 
serum total-cholesterol 
1st quartile (n=462) 
2nd quartile (n=461) 
3rd quartile (n=462) 
4th quartile (n=463) 
0.16 (0.96) 
-0.02 (0.98) 
0.03 (0.98) 
-0.17 (1.04) 
ref. 
+3.6 years 
+2.6 years 
+6.6 years 
4.7 (0.5) 
5.3 (0.4) 
5.8 (0.4) 
6.6 (0.6) 
4.1 (0.5) 
4.8 (0.4) 
5.2 (0.4) 
6.1 (0.7) 
3.9 (0.5) 
4.6 (0.4) 
5.1 (0.5) 
6.0 (0.7) 
Daily smoking 
age 6-12 years 
Daily smoking 
age 12-18 years 
Daily smoking 
age 18-24 years 
Daily smoking (between ages 12-24 
years) 
No (n=1306) 
Yes  (n=491) 
0.04 (1.00) 
-0.13 (0.97) 
ref. 
+3.4 years 
All participants were 
non-smokers 
0 % 
71.3 % 
0 % 
94.5 % 
Values are means (standard deviations) of the performance in the paired associates learning (PAL)-test indicating learning and memory 
and of the cardiovascular risk factor values in the quartiles of the area under the curve (AUC)-variables for systolic blood pressure and 
serum total-cholesterol and for dichotomized early life (age 12-24 years) smoking. For the PAL component higher values indicate better 
performance.  
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*The difference in cognitive age has been calculated comparing the difference in the PAL-test performance between the risk factor
quartiles to our previous finding on the effect of age (-0.0.5 SD per year) on the PAL-test.18 The lowest quartile has been used as the 
reference category for all comparisons for cognitive age.  
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Table 2. Associations between cumulative burden of early life vascular risk factors (age 6-
24 years) and midlife visual and episodic memory and visuospatial associative learning 
(PAL-test) in 1733 YFS participants.  
ROW MODEL β coefficient (SE) p-value 
A Unadjusted bivariate models 
Systolic blood pressure -0.152 (0.023) <0.0001 
Serum total-cholesterol -0.122 (0.024) <0.0001 
Body mass index 0.018 (0.026) 0.490 
Smoking -0.182 (0.054) 0.001 
B Age and sex adjusted models 
Systolic blood pressure -0.067 (0.026) 0.010 
Serum total-cholesterol -0.064 (0.025) 0.010 
Body mass index -0.004 (0.025) 0.870 
Smoking -0.123 (0.053) 0.001 
C Multivariate model 1 
Systolic blood pressure -0.076 (0.028) 0.006 
Serum total-cholesterol -0.059 (0.025) 0.018 
Body mass index 0.026 (0.026) 0.315 
Smoking -0.140 (0.053) 0.008 
D Multivariate model 2 
Systolic blood pressure -0.064 (0.028) 0.023 
Serum total-cholesterol -0.053 (0.025) 0.037 
Body mass index 0.029 (0.026) 0.281 
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Smoking -0.140 (0.053) 0.008 
Values are β coefficients (standard errors) and p-values from linear models. Unadjusted models 
are conducted separately for variables indicating cumulative burden of early life (6-24 years) 
cardiovascular risk factors (i.e. systolic blood pressure, serum total-cholesterol and body mass 
index, adolescence and young adulthood smoking at the age of 12 to 24 years) without covariates. 
Age and sex adjusted models are conducted separately for each early life cardiovascular risk factor. 
In the multivariate model 1, all variables indicating cumulative burden of early life (6-24 years) 
cardiovascular risk factors are entered simultaneously in an age and sex adjusted model. The 
multivariate model 2 is adjusted additionally for childhood family income, adulthood 
antihypertension and dyslipidemia medications, and diagnoses of cardiovascular diseases and 
diabetes mellitus. Variables for cognitive performance (PAL-test) and cardiovascular risk factors 
are standardized (mean 0, standard deviation 1), thus the beta coefficients indicate the amount of 
change in the PAL-test performance in standard deviations when the cumulative burden (6-24 
years) of an early life risk factor increases one standard deviation. One standard deviation unit is 
equivalent to ~6 mmHg for systolic blood pressure, ~0.7 mmol/l (~27 mg/dL) for total-cholesterol 
and ~2.4 kg/m2 for body mass index. For smoking, the beta coefficient estimates the effect of daily 
smoking between ages 12-24 years. For the PAL-test, lower values indicate lower cognitive 
performance. In all models, the participants with missing data on any of the variables in the fully 
adjusted model were excluded from the analyses. 
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ONLINE APPENDIX 
SUPPLEMENTAL METHODS 
Cognition 
During the follow-up examination in 2011, a cognitive testing battery developed by the 
Cambridge Cognition (CANTAB®) was used to assess cognitive function among the YFS 
participants. The CANTAB® test is a computerized, predominantly non-linguistic and 
culturally neutral test focusing on a wide range of cognitive domains. The test is performed 
using a validated touch-screen computer system. The full test battery includes 25 individual 
tests from which, a suitable test battery for each particular study may be selected. In YFS, the 
test battery was selected so that it could be accomplished in 20-30 minutes, and included tests 
that are sensitive to aging.1,2 The tests included in the test battery measured several cognitive 
domains: 1) short term memory, 2) spatial working memory, 3) problem solving, 4) reaction 
time, 5) attention, 6) rapid visual processing, 7) visual memory, 8) episodic memory, and 9) 
visuospatial learning.  
Cognitive testing was performed during clinical examination. Due to the blood sampling 
included in the study protocol, the subjects came to the examinations after fasting at least 12 
hours. They were instructed to avoid smoking, heavy physical activity as well as drinking 
alcohol and coffee during the previous evening and the morning before the examinations. 
Before the cognitive testing the subjects were provided with a light snack including a whole 
meal oat-based snack biscuit, a small portion of fruit/berry oatmeal and weak fruit/berry 
squash.   
During cognitive testing the participants first conducted a motor screening test (MOT test) 
measuring psychomotor speed and accuracy. In this study, the motor screening test was 
considered as a training procedure where the participants were introduced to the equipment 
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used in the testing, and a screening tool to point out any difficulties in vision, movement, 
comprehension or ability to follow simple instructions. Paired associates learning test (PAL-
test) was used to assess visual and episodic memory as well as visuospatial associative learning 
containing aspects of both delayed response procedure and conditional learning. Spatial 
working memory test (SWM-test) was used to measure ability to retain spatial information 
and to manipulate items stored in the working memory, problem solving as well as the ability 
to conduct a self-organized search strategy. Reaction time test (RTI-test) assessed speed of 
response and movement on tasks where the stimulus was either predictable (simple location 
task) or unpredictable (five-choice location task). Rapid visual information test (RVP-test) 
was used to assess, visual processing, recognition and sustained attention.  
Each of the CANTAB® tests produced several variables. For this study, principal component 
analysis was conducted as a multivariate technique for data reduction and to identify 
components accounting for the majority of the variation within the cognition dataset. Principal 
component analysis was selected since it allows analyzing the major sources of variation in a 
multi-dimensional data without introducing inherent bias. Principal component analyses were 
performed separately for all individual tests. The first components resulting from these analyses 
were considered to represent cognitive performance related to the particular cognitive domain. 
After creating the test wise principal components their distributions were analyzed. The 
component for motor screening test was excluded from further analyses because it did not 
discriminate the subjects indicating a ceiling effect. All other components were normalized 
based on the rank order normalization procedure resulting in five separate variables, each with 
mean value of 0 and standard deviation (SD) of 1. 
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Covariates 
Age was defined in full years at the end of the year 2011. At the baseline, the sum of household 
income was assessed with an eight-category question and used as an indicator of the socio-
economic status of the family (hereafter family income). For this study, the original income 
categories were converted to correspond to the value of money in 2011, and after that combined 
into four categories: 1) <17 000 euros/year, 2) 17 000–27 000, 3) 27 000–37 000 euros/year, 
and 4) >37 000 euros/year. Data on antihypertensive (N=192) and dyslipidemia (N=72) 
medications were obtained from the questionnaires in the latest follow-up study (2011). 
Diagnoses of cardiovascular diseases (N=13) were adjudicated from the national hospital 
discharge register. Diagnoses of type 1 diabetes were self-reported in the last follow-up study 
(year 2011). Participants were classified as having type 2 diabetes if, at any of the follow-up 
visits (2001, 2007 or 2011-2012), their fasting plasma glucose value was equal or greater than 
7 mmol/l, or if they reported having the diagnosis made by a physician. In addition, individuals 
whose hemoglobin A1c was equal or greater than 6.5% (48 mmol/l) at 2011 follow-up or who 
reported taking glucose lowering medication at 2007 or 2011 follow-up were classified as 
having type 2 diabetes. Finally, type 2 diabetes diagnoses were obtained from the National 
Social Insurance Institution's Drug Reimbursement Registry (N=75). Furthermore, childhood 
academic performance of the study participant was expressed by grade point average that was 
calculated as a mean of grades in all individual school subjects reported in a questionnaire. In 
Finland, the school grades vary on a scale between 4 indicating failure (US grade: F) and 10 
indicating excellent knowledge and skills (US grade: A). In this study, the grade point average 
values were used as a proxy for childhood cognitive ability. Adulthood education was assessed 
with questionnaires at the follow-up studies in 2001, 2007 and 2011. For this study, the 
maximum years of education was determined as a continuous variable from self-reported data 
concerning total years of education. Apolipoprotein E (APOE) genotypes were analyzed with 
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2 single nucleotide polymorphisms (rs429358 and rs7412), and the APOE promoter 
polymorphisms −219 and + 113 (rs405509 and rs440446, respectively). In this study, subjects 
were divided into 1) apoEε4 carriers (at least one ε4 allele) and 2) non-carriers (no ε4 alleles). 
Physical activity was measured with a self-administered questionnaire at baseline and in all 
follow-ups. The questionnaire consisted of items on the frequency and intensity of physical 
activity, frequency of vigorous physical activity, hours spent on vigorous physical activity, 
average duration of a physical activity session, and participation in organized physical activity. 
A comprehensive physical activity index was calculated for baseline and each follow-up study 
similarly to previous studies.3 Mean of the adulthood (ages 24-49 years) physical activity 
indexes was considered as an indicator of physical activity level in this study. 
Statistical analyses 
Subject-specific curves for systolic BP, serum total-, HDL- and LDL-cholesterols, triglycerides 
and BMI were estimated by mixed model regression splines.4 The covariance structure for the 
longitudinal setting was modelled by allowing for subject specific regression spline 
coefficients, which were incorporated as random effects to the model. To avoid overfitting we 
reduced the number of knots (two knots on the calendar time from 1980 to 2011) for the 
subject-specific part from that of the fixed effects part (four knots on age from 3 to 34 years). 
The mean profile was allowed to vary across birth cohorts and sex in terms of possibly different 
fixed effects parts. Similar to the approach of Lai et al (2014), we then evaluated the area under 
the curve (AUC) as a measure of a long term burden of each of the measured attributes.5 For 
this study, the AUC variables for BP, serum total-, HDL- and LDL-cholesterols, triglycerides 
and BMI were defined separately for childhood (age 6-12 years), adolescence (12-18 years), 
young adulthood (18-24 years) and early life (6-24 years). For interpretability, the AUC 
variables were standardized resulting in normally distributed variables with mean 0 and SD 1.   
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To analyze the effect of risk factor clustering from childhood to young adulthood on cognitive 
performance at midlife, a variable indicating the number of risk factors during early life (6-24 
years) was created. First, the AUC variables for BP and serum total-cholesterol were 
dichotomized into 1) high risk factor level (≥ 75th percentile; coded as 1) and 2) low risk factor 
level (<75th percentile; coded as 0). Smoking status was dichotomized similarly into 1) smokers 
(coded as 1) and 2) non-smokers (coded as 0). Finally, the dichotomic variables for BP, serum 
total-cholesterol and smoking were summed to create the variable indicating the number of risk 
factors (range 0-3) during early life. The number of persons with three early life cardiovascular 
risk factors was substantially low (n=62) and therefore, the persons with 2 or 3 risk factors 
were considered as the highest group. A similar variable indicating the number of 
cardiovascular risk factors at the time of cognitive testing was formed based on the BP and 
serum total-cholesterol values (dichotomized from the 75th percentile similarly to the early life 
AUC variables) and smoking status during the latest follow-up study (range of the sum variable 
0-3). The number of participants with three cardiovascular risk factors in the latest follow-up 
study was low (n=28), and therefore, the persons with 2 or 3 risk factors were again addressed 
to the same category. Sensitivity analyses were additionally performed using cut-points of 70th, 
80th and 85th percentiles for continuous variables (Online table 5). 
To investigate whether the effect of cardiovascular risk factor clustering is attributable to risk 
factor exposure levels exceeding recommended guidelines, the age and sex specific guideline 
values were considered for systolic BP6, LDL-cholesterol7 and smoking.8 Each subject was 
classified as having risk factor levels below/above the recommended guidelines at each age 
point. Subsequently, the subjects were classified according to the number of risk factors (i.e. 
systolic BP, LDL-cholesterol and smoking) and times when they had risk factor levels 
exceeding the guidelines between ages 6-24 into: 1) no risk factor levels exceeding guidelines 
or levels exceeding guidelines at most once on each risk factor, 2) risk factor levels exceeding 
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guidelines on one risk factor twice or more, 3) risk factor levels exceeding guidelines twice or 
more on two risk factors, 4) risk factor levels exceeding guidelines twice or more on all risk 
factors.  
Associations between two categorical variables were studied with χ2-test, while Student’s t-test 
was applied for analyses for continuous variables. Linear regression analyses were conducted 
to investigate the associations between childhood / adolescence / young adulthood BP, serum 
total-, HDL- and LDL-cholesterols, serum triglycerides, BMI and principal components for 
midlife cognitive performance. First, age and sex adjusted regression analyses were conducted 
separately for cumulative burden of each cardiovascular risk factor in childhood, adolescence 
and young adulthood using each cognitive domain as outcome. After that, these analyses were 
adjusted additionally for family income, antihypertension and dyslipidaemia medication and 
diagnoses of cardiovascular diseases and diabetes mellitus. 
Second, further analyses were conducted for visual and episodic memory and 
visuospatial associative learning (PAL-test) which was the cognitive domain showing most 
consistent results in the analyses separately for each early life cardiovascular risk factors. These 
analyses were conducted first unadjusted, and then entering age and sex as covariates. After 
that, all early life cardiovascular risk factors were entered in the same age and sex adjusted 
model. Finally, the analyses were additionally adjusted for family income, antihypertension 
and dyslipidaemia medication and diagnoses of cardiovascular diseases and diabetes mellitus. 
Additional analyses were conducted adjusting the models additionally for childhood academic 
performance, apoEε4 genotype, and adulthood physical activity level to analyze whether these 
factors act as mediators in the found associations. Additionally, we analyzed the possible 
interaction between cardiovascular risk factors and sex or age by adding interaction terms in 
the fully adjusted models (e.g. ‘sex*serum total-cholesterol’ or ‘age*serum total-cholesterol’). 
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All statistical analyses were performed using SAS 9.4 and the level of statistical significance 
was set at p<0.05. 
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Online Table 1. Age and sex specific mean values of systolic blood pressure, total-and LDL-
cholesterol among participants in the highest 75th percentile in the area under the curve 
(AUC) variables between ages 6-24 years. 
Mean (SD) 
Boys/Girls 
Systolic blood pressure, mmHg 
Age 6 years 
Age 9 years 
Age 12 years 
Age 15 years 
Age 18 years 
Age 21 years 
Age 24 years 
112.16 (7.00) / 118.11 (9.31) 
117.79 (8.76) / 120.39 (8.92) 
117.35 (8.78) / 122.30 (9.04) 
127.36 (10.16) / 127.67 (9.17) 
131.82 (9.99) / 128.37 (9.94) 
135.28 (9.39) / 131.96 (7.08) 
133.94 (8.78) / 131.88 (10.33) 
Serum total-cholesterol, mmol/l 
Age 6 years 
Age 9 years 
Age 12 years 
Age 15 years 
Age 18 years 
Age 21 years 
Age 24 years 
5.38 (0.94) / 5.71 (0.98) 
5.44 (0.88) / 5.64 (1.17) 
5.29 (0.94) / 5.42 (1.07) 
4.74 (0.90) / 5.29 (1.18) 
4.89 (0.97) / 5.32 (1.21) 
5.04 (1.03) / 5.26 (0.94) 
5.00 (0.98) / 5.13 (0.92) 
Serum LDL-cholesterol, mmol/l 
Age 6 years 
Age 9 years 
Age 12 years 
Age 15 years 
Age 18 years 
Age 21 years 
Age 24 years 
3.44 (0.90) / 3.76 (0.92) 
3.39 (0.79) / 3.63 (1.12) 
3.29 (0.85) / 3.44 (0.99) 
2.91 (0.84) / 3.29 (1.10) 
3.07 (0.93) / 3.33 (1.16) 
3.07 (0.94) / 3.15 (0.82) 
3.06 (0.94) / 3.03 (0.79) 
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The values of serum total- and LDL-cholesterol are converted into mg/dl by multiplying the 
values in mmol/l by 39.  
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Online Table 2. Cut-points for the recommended guidelines for systolic blood pressure and 
low density lipoprotein cholesterol. 
Cut-point values 
(boys / girls) 
Systolic blood pressure, mmHg 
Age 6 years  
Age 9 years  
Age 12 years 
Age 15 years 
Age 18 years 
Age 21 years 
Age 24 years 
105.0 / 104.0 
109.0 / 110.0 
115.0 / 116.0 
120.0 / 120.0 
120.0 / 120.0 
120.0 / 120.0 
120.0 / 120.0 
Serum LDL-cholesterol, mmol/l 
Age 6 years  
Age 9 years  
Age 12 years 
Age 15 years 
Age 18 years 
Age 21 years 
Age 24 years 
2.38 / 2.38 
2.38 / 2.38 
2.50 / 2.38 
2.38 / 2.43 
2.51 / 2.52 
2.59 / 2.59 
2.59 / 2.59 
Values are age and sex specific cut-point values for recommended guidelines for systolic 
blood pressure (Kaelber DC et al. Pediatrics. 2009;123(6):e972-4) and low density 
lipoprotein cholesterol (Jolliffe CJ et al. Circulation. 2006;114(10):1056-1062). The values of 
serum LDL-cholesterol are converted into mg/dl by multiplying the values in mmol/l by 39.  
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Online Table 3. Characteristics of the study population. 
All 
(N=2026) 
Men 
(N=922) 
Women 
(N=1104) 
Background characteristics 
Age, years (N=2026) 
At baseline 10.8 (5.0) 10.7 (5.1) 10.9 (5.0) 
At cognitive testing 41.8 (5.0) 41.7 (5.1) 41.9 (5.0) 
Family income at baseline, N (%), (N=1956) 
  <17 000 euros/year 512 (26.2) 229 (25.7) 283 (26.6) 
  17 000–27 000 euros/year 575 (29.4) 270 (30.3) 305 (28.6) 
  27 000–37 000 euros/year 425 (21.7) 191 (21.5) 234 (22.0) 
  >37 000 euros/year 444 (22.7) 200 (22.5) 244 (22.9) 
Childhood academic performance (N=1777) 7.77 (0.7) 7.57 (0.7) 7.94 (0.7) 
ApoE ε4 carriers (≥one ε4 allele) (N=1909) 680 (35.6) 314 (36.6) 366 (34.8) 
Early life smoking, N (%), yes (N=1968) 544 (27.6) 291 (32.6) 253 (23.5) 
Physical activity index (range 5-15), (N=2005) 9.21 (1.72) 9.14 (1.84) 9.26 (1.62) 
Cardiovascular risk factors at baseline 
Systolic blood pressure, mmHg (N=2009) 112.8 (11.9) 113.8 (13.0) 112.0 (10.9) 
Diastolic blood pressure, mmHg (N=1732) 68.6 (9.4) 68.9 (9.6) 68.3 (9.2) 
Total-cholesterol, mmol/l (N=2003) 5.3 (0.9) 5.2 (0.9) 5.4 (0.9) 
HDL-cholesterol, mmol/l (N=2002) 1.6 (0.3) 1.6 (0.3) 1.6 (0.3) 
LDL-cholesterol, mmol/l (N=2002) 3.4 (0.8) 3.4 (0.8) 3.5 (0.8) 
Triglycerides, mmol/l (N=2003) 0.7 (0.3) 0.7 (0.3) 0.7 (0.3) 
Body mass index, kg/m2 (N=2011) 18.0 (3.1) 18.0 (3.2) 17.9 (3.1) 
Cardiovascular risk factors at cognitive 
testing 
Systolic blood pressure, mmHg (N=2019) 118.9 (14.1) 122.9 (13.3) 115.6 (13.8) 
Diastolic blood pressure, mmHg (N=2019) 74.9 (10.5) 77.8 (10.8) 72.4 (9.5) 
Total-cholesterol, mmol/l (N=2008) 5.2 (1.0) 5.3 (1.0) 5.1 (0.9) 
HDL-cholesterol, mmol/l (N=2006) 1.3 (0.3) 1.2 (0.3) 1.4 (0.3) 
LDL-cholesterol, mmol/l (N=1961) 3.3 (0.8) 3.4 (0.9) 3.1 (0.8) 
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Triglycerides, mmol/l (N=2008) 1.3 (1.2) 1.6 (1.2) 1.1 (1.2) 
Body mass index, kg/m2 (N=2020) 26.5 (5.1) 27.0 (4.4) 26.1 (5.5) 
Area under the curve (AUC) variables for 
cardiovascular risk factors 
Childhood (6-12 years), mean (SD) 
Systolic blood pressure, mmHg*yrs (N=2026) 647.5 (31.9) 646.0 (32.4) 648.8 (31.5) 
Total-cholesterol, mmol/l*yrs (N=2026) 33.1 (4.0) 32.8 (4.1) 33.3 (3.9) 
HDL-cholesterol, mmol/l*yrs (N=2026) 9.1 (1.4) 9.2 (1.4) 8.9 (1.4) 
LDL-cholesterol, mmol/l*yrs (N=2026) 22.1 (4.3) 21.6 (4.3) 22.5 (4.2) 
Triglycerides, mmol/l*yrs (N=2026) 3.8 (1.1) 3.6 (1.1) 3.9 (1.1) 
Body mass index, kg/m2*yrs (N=2026) 99.7 (9.7) 100.0 (9.8) 99.4 (9.6) 
Adolescence (12-18 years), mean (SD) 
Systolic blood pressure, mmhg*yrs (N=2026) 685.8 (40.6) 699.3 (40.0) 674.5 (37.6) 
Total-cholesterol, mmol/l*yrs (N=2026) 29.4 (4.1) 28.4 (4.0) 30.2 (4.0) 
HDL-cholesterol, mmol/l*yrs (N=2026) 8.7 (1.4) 8.3 (1.3) 9.0 (1.4) 
LDL-cholesterol, mmol/l*yrs (N=2026) 18.4 (3.9) 17.9 (3.9) 18.9 (3.8) 
Triglycerides, mmol/l*yrs (N=2026) 4.9 (1.4) 4.8 (1.4) 5.0 (1.3) 
Body mass index, kg/m2*yrs (N=2026) 120.6 (14.3) 120.5 (14.4) 120.6 (14.2) 
Young adulthood (18-24 years), mean (SD) 
Systolic blood pressure, mmHg*yrs (N=2026) 713.2 (53.1) 746.2 (45.6) 685.7 (42.1) 
Total-cholesterol, mmol/l*yrs (N=2026) 29.4 (4.2) 28.3 (4.1) 30.4 (4.1) 
HDL-cholesterol, mmol/l*yrs (N=2026) 8.1 (1.6) 7.2 (1.3) 8.8 (1.5) 
LDL-cholesterol, mmol/l*yrs (N=2026) 17.7 (3.7) 17.2 (3.7) 18.1 (3.7) 
Triglycerides, mmol/l*yrs (N=2026) 6.2 (1.6) 6.2 (1.7) 6.2 (1.5) 
Body mass index, kg/m2*yrs (N=2026) 135.2 (17.3) 138.1 (16.9) 132.8 (17.2) 
Cognitive components, mean (SD) 
PAL-test (N=1848) Cognitive 
components 
were 
standardized; 
mean 0, SD 1 
-0.1 (1.0) 0.1 (1.0) 
SWM-test (N=2011) 0.2 (1.0) -0.2 (1.0) 
RTI-test (N=1822) 0.2 (1.0) -0.2 (0.9) 
RVP-test (N=1975) 0.1 (1.0) -0.1 (1.0) 
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Values are means (standard deviations) for continuous variables and numbers (percentages) 
for categorical variables. Student’s t-test and χ2-test were used. Early life smoking was 
dichotomized into those smoking at any follow-up phase between ages 12-24. Family income 
was measured as sum of participants’ parents’ income and transformed to correspond with 
the current value of money. Physical activity index was calculated as a mean of adulthood 
(ages 24-29 years) physical activity indexes that were created based on data queried at each 
follow-up study on frequency and intensity of physical activity, frequency of vigorous 
physical activity, hours spent on vigorous physical activity, average duration of a physical 
activity session, and participation in organized physical activity (range 5-15). Principal 
component analyses was used to calculate components indicating visual and episodic 
memory and visuospatial associative learning (PAL-test), working memory and problem 
solving (SWM-test), reaction time (RTI-test) and recognition, visual processing and sustained 
attention (RVP-test) based on CANTAB® cognitive test battery. All comparisons between 
men and women were statistically significant (p<0.05) except for age at baseline and at the 
follow-up, family income, apoE ε4 allele, adulthood physical activity index, baseline diastolic 
blood pressure, baseline HDL-cholesterol, baseline body mass index, childhood and 
adolescence AUC’s for body mass index, and young adulthood triglycerides for which the 
comparisons were non-significant. The values of serum total-, HDL- and LDL-cholesterol are 
converted into mg/dl by multiplying the values in mmol/l by 39. The values for triglycerides 
are converted into mg/dl by multiplying the values in mmol/l by 89.  
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Online Table 4. Baseline and early life characteristics of participants and non-participants.  
 Participants 
(N=2026) 
Non-participants 
(N=1570) 
P-value 
Sex, male  922 (45.51) 842 (53.63) <0.0001 
Age at baseline, years  10.84 (5.01) 9.92 (4.92) <0.0001 
Family income at baseline, N (%)     
  <17 000 euros/year 512 (26.18) 438 (29.26)  
  17 000–27 000 euros/year  575 (29.40) 479 (32.00)  
  27 000–37 000 euros/year  425 (21.73) 309 (20.64) 0.003 
  >37 000 euros/year  444 (22.70) 271 (18.10)  
Early life smoking, N (%) 544 (27.64) 397 (28.14) 0.752 
Childhood academic performance  7.77 (0.73) 7.65 (0.74) <0.0001 
ApoE ε4 carriers (≥one ε4 allele) 680 (35.62) 273 (37.19) 0.451 
Systolic blood pressure, mmHg 112.80 (11.92) 112.21 (12.53) 0.165 
Diastolic blood pressure, mmHg 68.58 (9.39) 69.02 (9.84) 0.221 
Total-cholesterol, mmol/l 5.29 (0.90) 5.31 (0.93) 0.551 
HDL-cholesterol, mmol/l 1.56 (0.31) 1.56 (0.31) 0.939 
LDL-cholesterol, mmol/l 3.42 (0.82) 3.45 (0.86) 0.427 
Triglycerides, mmol/l 0.67 (0.31) 0.66 (0.32) 0.434 
Body mass index, kg/m2 17.97 (3.12) 17.69 (3.10) 0.009 
 
Values are means (standard deviations) for continuous variables and number of subjects 
(percentages) for categorical variables. Age and sex adjusted p-values were calculated using 
linear models. The participants are subjects who participated in the cognitive testing during the 
latest follow-up study of the Cardiovascular Risk in Young Finns Study. The non-participants 
are subjects who did not participate in cognitive testing. Blood pressure, serum lipids and body 
mass index are measured at the baseline. Early life smoking was dichotomized into those 
smoking at any follow-up phase between ages 12-24. Family income was measured as sum of 
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participants’ parents’ income, transformed to correspond with the current value of money. 
Grade point average (range from 4.0 to 10.0) is calculated as the mean of grades on all school 
subjects at baseline or either of the two following follow-ups (for those participants who were 
not of school age at the baseline). Grade point average is considered as a measure of childhood 
academic performance. The values of serum total-, HDL- and LDL-cholesterol are converted 
into mg/dl by multiplying the values in mmol/l by 39. The values for triglycerides are converted 
into mg/dl by multiplying the values in mmol/l by 89.
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Online Table 5. Associations between childhood, adolescence and young adulthood cardiovascular risk factors and midlife cognitive 
performance. 
 Childhood 
(6-12 years) 
Adolescence 
(12-18 years) 
Young adulthood 
(18-24 years) 
 β coefficient (SE) p-value β coefficient (SE) p-value β coefficient 
(SE) 
p-value 
Systolic blood pressure       
  PAL-test -0.058 (0.023) 0.013 -0.067 (0.026) 0.011 -0.097 (0.030) 0.001 
  SWM-test 0.006(0.022) 0.770 -0.001 (0.025) 0.956 -0.012 (0.029) 0.681 
  RTI-test 0.039 (0.024) 0.103 0.036 (0.027) 0.180 0.028 (0.030) 0.360 
  RVP-test -0.020 (0.023) 0.393 -0.034 (0.026) 0.196 -0.046 (0.030) 0.121 
Diastolic blood pressure       
  PAL-test -0.024 (0.027) 0.382 -0.035 (0.027) 0.185 -0.053 (0.025) 0.035 
  SWM-test 0.032 (0.026) 0.216 0.029 (0.026) 0.264 0.020 (0.024) 0.406 
  RTI-test 0.027 (0.028) 0.328 -0.008 (0.027) 0.761 -0.009 (0.025) 0.728 
  RVP-test -0.030 (0.027) 0.266 -0.025 (0.027) 0.348 -0.028 (0.025) 0.266 
Serum total-cholesterol       
  PAL-test -0.063(0.025) 0.010 -0.066 (0.025) 0.009 -0.066 (0.024) 0.007 
  SWM-test -0.031 (0.023) 0.180 -0.027(0.024) 0.263 -0.019 (0.023) 0.427 
  RTI-test 0.003 (0.025) 0.917 -0.001 (0.026) 0.976 -0.005 (0.025) 0.836 
  RVP-test -0.046 (0.025) 0.063 -0.047 (0.025) 0.062 -0.050 (0.024) 0.041 
Serum LDL-cholesterol       
  PAL-test -0.059 (0.028) 0.031 -0.056 (0.025) 0.025 -0.052 (0.023) 0.024 
  SWM-test -0.044 (0.026) 0.091 -0.036 (0.024) 0.133 -0.021 (0.022) 0.333 
  RTI-test -0.013 (0.028) 0.635 -0.016 (0.025) 0.515 -0.012 (0.024) 0.613 
  RVP-test -0.047 (0.027) 0.084 -0.039(0.025) 0.119 -0.041 (0.023) 0.078 
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Online Table 5. Associations between childhood, adolescence and young adulthood vascular risk factors and midlife cognitive performance 1 
(continued). 2 
Childhood 
(6-12 years) 
Adolescence 
(12-18 years) 
Young adulthood 
(18-24 years) 
β coefficient 
(SE) 
p-value β coefficient 
(SE) 
p-value β coefficient 
(SE) 
p-value 
Serum HDL-cholesterol 
  PAL-test -0.064 (0.037) 0.087 -0.059 (0.035) 0.098 -0.048 (0.031) 0.117 
  SWM-test -0.020 (0.036) 0.576 -0.016 (0.034) 0.640 -0.019 (0.029) 0.519 
  RTI-test 0.020 (0.038) 0.594 0.014 (0.036) 0.708 -0.003 (0.031) 0.919 
  RVP-test -0.014 (0.038) 0.706 -0.012 (0.036) 0.746 -0.001 (0.031) 0.980 
Serum triglycerides 
  PAL-test -0.045 (0.027) 0.093 -0.053 (0.027) 0.049 -0.042 (0.022) 0.055 
  SWM-test -0.034 (0.026) 0.182 -0.012 (0.025) 0.647 -0.001 (0.021) 0.972 
  RTI-test -0.030 (0.028) 0.283 0.001 (0.027) 0.976 -0.010 (0.022) 0.646 
  RVP-test -0.031 (0.027) 0.242 -0.053 (0.027) 0.045 -0.040 (0.022) 0.070 
Body mass index 
  PAL-test -0.020 (0.024) 0.415 -0.014 (0.025) 0.570 -0.009 (0.024) 0.709 
  SWM-test 0.027 (0.023) 0.240 0.026 (0.023) 0.272 0.034 (0.023 0.149 
  RTI-test 0.024 (0.025) 0.324 0.020 (0.025) 0.414 0.005 (0.025) 0.850 
  RVP-test -0.036 (0.024) 0.136 -0.052 (0.024) 0.034 -0.076 (0.024) 0.024 
Adolescence and young adulthood (12-24 years) 
Smoking β coefficient (SE) p-value 
  PAL-test All 6-12-year-old 
participants were 
non-smokers 
-0.123 (0.053) 0.020 
  SWM-test 0.020 (0.050) 0.692 
  RTI-test -0.037 (0.053) 0.489 
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  RVP-test -0.116 (0.052) 0.027 
1 
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The values are β coefficients (standard errors) and p-values from linear models. Variables for cognitive performance and cardiovascular risk factors 
are standardized (mean 0, standard deviation 1) and thus the beta coefficients indicate the amount of change in standard deviations when risk factors 
increase one standard deviation. All models were adjusted for age and sex. Systolic and diastolic blood pressure, serum lipids and body mass index 
were treated as continuous variables. Principal component analyses was used to calculate components indicating visual and episodic memory and 
visuospatial associative learning (PAL-test), working memory and problem solving (SWM-test), reaction time (RTI-test) and recognition, visual 
processing and sustained attention (RVP-test) based on CANTAB cognitive test battery. In the variables for cognitive performance, lower values 
indicate lower cognitive performance. The analyses were conducted using all available data for each cognitive test; in the analyses for systolic and 
diastolic blood pressure, serum total- and LDL-cholesterol, serum triglycerides, and body mass index N=1781 in the PAL-test, N=1941 in the SWM-
test, N=1756 in the RTI-test, and N=1906 in the RVP-test. In the analyses for HDL-cholesterol N=1780 in the PAL-test, N=1940 in the SWM-test, 
N=1755 in the RTI-test, and N=1905 in the RVP-test and in the analyses for smoking N=1733 in the PAL-test, N=1886 in the SWM-test, N=1708 
in the RTI-test, and N=1851 in the RVP-test. 
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Online Table 6. Sensitivity analyses for the number of early and midlife cardiovascular risk factors. 
Extreme 70th  
percentile 
Extreme 75th 
percentile 
Extreme 80th 
percentile 
Extreme 85th 
percentile 
β estimate (SE) p-value β estimate (SE) p-value β estimate (SE) p-value β estimate (SE) p-value 
Univariate models 
Number of early 
life  
risk factors 
Number of midlife 
risk factors 
-0.136 (0.033) 
-0.090 (0.032) 
<0.001 
0.006 
-0.135 (0.034) 
-0.078 (0.034) 
<0.001 
0.022 
-0.120 (0.035) 
-0.063 (0.035) 
<0.001 
0.071 
-0.111 (0.037) 
-0.061 (0.037) 
0.002 
0.103 
Multivariate model 
Number of early 
life risk factors 
Number of midlife 
risk factors 
-0.115 (0.035) 
-0.056 (0.035) 
0.001 
0.110 
-0.119 (0.036) 
-0.045 (0.037) 
0.001 
0.220 
-0.107 (0.038) 
-0.035 (0.038) 
0.004 
0.351 
-0.099 (0.039) 
-0.038 (0.040) 
0.011 
0.345 
A 3-level variable indicating the number of risk factors during early (age 6-24 years) and midlife (at the latest follow-up in 2011; age 34-49 years) 
was created from the area under the curve (AUC) variables for each cardiovascular risk factor (1=no risk factors, 2=one risk factor, 3=two or three 
risk factors). The AUC variables for BP and serum total-cholesterol were dichotomized into high risk factor level (≥ 70th/75th/80th/85th percentile) 
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and low risk factor level (<70th/75th/80th/85th percentile). Smoking status was dichotomized into smokers and non-smokers. The dichotomical 
variables were summed to create the variable indicating the number of risk factors (range 0-3) during early life and at midlife. The univariate 
models were conducted separately for variables indicating the number of early life and midlife risk factors. In the multivariate model, the variables 
indicating the number of early life and midlife risk factors were entered simultaneously in the analysis. All analyses were adjusted for age, sex, 
family income, hypertension and dyslipidemia medications and diagnoses of cardiovascular diseases and diabetes mellitus.  
